- This retrospective analysis of the ELSO registry included 115,849 adults on ECMO across 495 hospitals from 2012 to 2023.
- Hospital ECMO experience was measured by annual adult case counts and total ECMO hours, and the analysis compared centers with four or more adult ICUs to those with one.
- Higher annual case counts were associated with lower in-hospital mortality odds (OR 0.98, 95% CI 0.97-0.99 per 10 cases), with a similar but smaller association for ECMO hours.
- Centers delivering ECMO across four or more ICUs had higher adjusted mortality than one-ICU centers (OR 1.18, 95% CI 1.06-1.31), which the authors partly attribute to case complexity and offset by volume.
Cardiac
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Retrospective cohort of 4,358 adults undergoing cardiac surgery with cardiopulmonary bypass at one tertiary center, 2018 to 2024.
- Exposure was time-weighted average indexed oxygen delivery (DO2i) during bypass, calculated from pump flow, saturation, hemoglobin and body surface area, analyzed as a continuous variable.
- Each 10 ml/min/m² decrease in DO2i was associated with higher odds of 30-day mortality (adjusted OR 1.16; 95% CI 1.09-1.23; P < 0.001); 75 patients (1.7%) died.
- Adjusted 30-day mortality was 1.69% at the 25th DO2i percentile versus 0.74% at the 75th; lower DO2i was also linked to AKI and longer ICU and hospital stay, but not stroke.
- Systematic review and meta-analysis of 38 studies (30 randomized, 8 observational; 7,494 patients) comparing digital health interventions with standard care after non-cardiac surgery.
- Interventions were grouped by whether a clinician reviewed patient-submitted data and could act on it, versus no such clinician involvement.
- Digital health interventions were associated with fewer readmissions (RR 0.85, 95% CI 0.73-0.99, adjusted p=0.045), ER visits, and major complications, but not all-cause complications or length of stay.
- The readmission reduction was seen with active clinician involvement (RR 0.76, 95% CI 0.64-0.92) but not without it (RR 0.96, 95% CI 0.78-1.18; interaction p=0.029).
- This narrative review synthesizes evidence on preoperative anemia, RBC transfusion, and postoperative outcomes in cardiac surgery patients.
- It emphasizes causal inference mediation analysis to separate the direct effects of anemia from transfusion-mediated effects.
- The authors suggest transfusion mediates a substantial share of anemia-associated mortality, while direct anemia effects seem more important for renal complications.
- They argue for individualized transfusion strategies over uniform thresholds, weighing the benefits of correcting anemia against transfusion risks for each outcome.
- Single-blind multicenter randomized trial at 10 French tertiary centers enrolled 172 adults undergoing elective cardiac surgery with cardiopulmonary bypass; stopped early by the data and safety monitoring board.
- Individualized MAP targeting (within ±10% of preoperative baseline, intraoperatively and for 24 hours postoperatively) was compared with a standard target MAP of at least 65 mm Hg.
- The primary composite occurred in 32% versus 29% (relative risk 1.1; 95% CI 0.7 to 1.8; P=0.76), while hemorrhagic complications were 18% versus 3% (P=0.003).
- The authors could not determine whether individualized MAP reduced major postoperative complications and flagged the increased bleeding as a safety signal for future studies.
- This state-of-the-art review covers delirium epidemiology, mechanisms, diagnosis, prevention and treatment across cardiovascular medicine, drawing on interdisciplinary expert input.
- It identifies risk factors such as advanced age, baseline cognitive impairment, cerebrovascular disease, longer operative times, complications and systemic inflammation.
- Non-pharmacological multicomponent prevention is described as strongly supported, while preventive pharmacologic use remains controversial; dexmedetomidine is noted for ICU settings.
- The authors conclude that systematic risk assessment and multimodal prevention should be standard care, with more high-quality studies needed for cardiovascular-specific guidelines.
- Nationwide retrospective cohort of adults undergoing elective open cardiac valve surgery at 40 Spanish centers (2016-2024), with 20,017 patients having preoperative hemoglobin data.
- Compared WHO sex-specific anemia criteria with a uniform Hb <13.0 g/dL threshold for RBC transfusion risk, using mixed-effects models adjusted for case mix and center.
- Among women with Hb 12.0-12.9 g/dL, 68.0% received RBC transfusion versus 52.7% of men; adjusted probability difference 15.1 percentage points (95% CI, 11.4-18.9), adjusted OR 1.85 (95% CI, 1.59-2.16).
- Sex did not significantly modify the Hb associations with complications or 30-day in-hospital mortality, and the authors frame Hb <13.0 g/dL as a sex-inclusive trigger for risk recognition, not a proven therapeutic target.
- Retrospective cohort of adult cardiac surgery patients using cell salvage, analyzed as a routine coagulation cohort (N = 677) and an exploratory viscoelastic cohort (N = 50).
- Exposure was cell salvage reinfusion volume, with paired hemostatic measurements before and after and no coagulation-affecting blood products between them.
- In the routine coagulation cohort, CS volume was not significantly associated with absolute changes in any parameter (all p ≥ 0.144).
- In the viscoelastic cohort, higher CS volume was associated with lower functional fibrinogen clot strength (CFF MA β = -3.31 mm/L; 95% CI -5.53 to -1.08; adjusted p = 0.031), while the CK MA association did not survive correction.
- This single-center, retrospective before-after study compared 229 elective cardiac surgery patients on an ERAS-PBM pathway with 162 pre-ERAS patients from 2019.
- The ERAS-PBM pathway added preoperative anemia screening and treatment, adherence to restrictive transfusion thresholds, blood conservation, and care bundles run by an ERAS nurse.
- RBC transfusion fell from 38.9% to 23.6% (p = 0.0012), and the exploratory adjusted OR for transfusion was 0.59 (95% CI 0.36-0.98; p = 0.041).
- Complications fell from 66.7% to 46.3% and hospital stay shortened from 12 to 9 days, and the authors call for larger multicenter prospective studies.
- Retrospective multicenter cohort of 1,377 children with in-hospital cardiac arrest treated with ECPR, from ELSO registry hospitals in 2020 to 2023, split into 1,060 derivation and 317 validation patients.
- No intervention was compared; a penalized logistic regression (LASSO) model used 14 routinely available clinical variables to predict survival to hospital discharge, then fed hospital-level risk-standardized survival rates.
- The model showed fair discrimination (AUC 0.728 derivation, 0.678 validation) and good calibration (observed-to-expected ratio 0.995, Brier score 0.222 in validation).
- Between-hospital variation had a median odds ratio of 1.30 (95% CI, 1.11-1.93); the authors state external validation and case-mix review are needed before benchmarking.
- This narrative review synthesizes fourteen original studies covering nearly 220,000 patients from over 1,000 centres worldwide.
- It focuses on platelet concentrate and fresh frozen plasma use in adult cardiac surgery and how hemostatic therapy varies between centres.
- Platelet and plasma transfusion rates differed significantly across centres, and patient and procedural characteristics do not fully explain these differences.
- Viscoelastic tests have improved assessment in some settings but have not eliminated variation, which the authors attribute partly to hospital culture, organization, thresholds and human factors.
- Randomized, double-blind, placebo-controlled single-center trial of 70 patients undergoing on-pump CABG.
- Patients received intranasal dexmedetomidine 1 μg/kg or saline on the night before surgery and again 30 minutes before induction.
- At 24 hours, estimated marginal mean hs-cTnT was 170.29 vs 357.29 ng/L (P < 0.001) favoring dexmedetomidine; CK-MB was also lower.
- Sleep quality scores were higher and postoperative delirium was lower (14.3% vs 37.1%; P = 0.029), but the authors call the findings preliminary.
- Retrospective single-center cohort of 229 children with culture-positive postoperative sepsis after congenital heart surgery, 2018 to 2022.
- Serial neutrophil-to-lymphocyte ratio was measured preoperatively, at sepsis diagnosis, and on days 7 and 14, and compared between survivors and nonsurvivors.
- Sixty-six patients (28.8%) died in hospital; day 7 NLR had the best discrimination for mortality (AUC 0.74, 95% CI 0.67-0.81).
- After multivariable adjustment, NLR at sepsis diagnosis (OR 1.06, 95% CI 1.01-1.12) and on day 7 (OR 1.04, 95% CI 1.01-1.08) were each independently associated with in-hospital mortality.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- Single-center retrospective before-and-after cohort with propensity matching in a cardiothoracic ICU compared 122 ketamine and 122 control patients after cardiac surgery.
- Patients on an ERAS pathway received a continuous low-dose ketamine infusion (0.1-0.3 mg/kg/h) or no ketamine as the control.
- Cumulative opioid use over POD0-2 was lower with ketamine (30 vs 52.5 MME; p = 0.003), and time to first analgesic was longer (7.4 vs 4.5 h; p < 0.001).
- No hallucinations were seen and urinary retention fell (9.8% vs 34%; p < 0.001), and the authors describe ketamine as a safe adjunct.
- Secondary analysis of data from a randomized trial, with 50 cardiac surgery patients propensity-matched 1:20 to 989 historic institutional patients receiving standard care.
- The comparison was continuous serratus anterior plane catheters versus standard care, with matching on age, sex, smoking, surgery type and pre-existing respiratory disease.
- Pneumothorax occurred more often with catheters (12% vs 3%; OR 5.3; 95% CI 2.1 to 13.6; P < 0.001), while ICU readmission, ventilation and length of stay did not differ.
- The authors found the catheter group had more pneumothorax but note causality is unclear, possibly reflecting trial monitoring differences and baseline population risk.
- Retrospective multicenter cohort using MIMIC-IV and eICU data included 2,556 adults having isolated CABG who needed mechanical ventilation for at least 24 hours.
- Patients were grouped by mean RASS in the first 24 hours after ICU admission: deep sedation (≤-3), light sedation (reference), or agitation (≥1).
- Deep sedation was linked to higher in-hospital mortality (41.0% vs 14.1%), and this persisted after adjustment (mixed-model OR 3.17, 95% CI 2.52-4.00).
- Mortality followed a J-shaped curve with the lowest risk at RASS -1 to 0, and the authors frame these hypothesis-generating findings as needing prospective validation.
- This exploratory substudy of the open-label randomized MERCURI-1 trial enrolled adults undergoing cardiac surgery with cardiopulmonary bypass at an academic university hospital.
- Patients received empagliflozin 10 mg/day from 3 days before surgery until 2 days after, or standard perioperative care.
- Endothelin-1, angiopoietin-2, and syndecan-1 changes did not differ significantly between groups; for endothelin-1 the adjusted difference was 0.097 pg/mL (95% CI -0.478 to 0.672, p = 0.735).
- The authors found no significant differences in cardiac injury or inflammatory biomarkers, and noted that smaller treatment effects cannot be excluded given the limited sample size.
- Retrospective single-centre cohort of 8198 adults undergoing cardiac surgery with cardiopulmonary bypass between 2013 and 2021, with AKI defined by KDIGO criteria within 7 postoperative days.
- Compared vancomycin plus gentamicin prophylaxis (729 patients, 9%) with cephalosporin prophylaxis (7469 patients, 91%).
- AKI occurred in 29% of the vancomycin-gentamicin group versus 15% of the cephalosporin group; after adjustment the odds ratio was 1.29 (95% CI 1.03 to 1.62, P = 0.024), and 1.32 (95% CI 1.09 to 1.60, P = 0.005) by propensity score.
- The association was significant in high-risk patients (OR 1.53, 95% CI 1.14 to 2.04) but not low-risk patients (OR 1.19, 95% CI 0.87 to 1.64), and the authors suggest alternatives be considered in high-risk patients when possible.
- Prospective study of 50 children undergoing cardiac surgery with cardiopulmonary bypass, with blood sampled after induction, 30 minutes post-bypass, and 24 hours post-bypass.
- Serum NSE, S100ß, and the cytokines IL-6, IL-8, and IL-10 were measured at each time point and compared with bypass and cross-clamp durations and postoperative neurological outcome.
- NSE and S100ß rose significantly after bypass and correlated with the cytokines and with bypass duration; only three patients had neurological insult, who had higher NSE post-bypass (p = 0.02) and S100ß at 24 hours (p = 0.02).
- The authors suggest the systemic inflammatory response to bypass may contribute to neurological injury and that NSE and S100ß may help detect it after bypass.
- This educational review traces the history of pediatric congenital cardiac anesthesia, from the first patent ductus arteriosus ligation in 1938 to current practice.
- It covers advances in surgery, bypass technology, myocardial protection, monitoring, intensive care, and anesthetic management that enabled survival into adulthood for most children with CHD.
- The specialty's focus has shifted from reducing perioperative mortality to improving lifelong outcomes as the adult CHD population has grown.
- The authors conclude that multidisciplinary collaboration and continued scientific progress are central to improving safety, recovery, and long-term outcomes.
- This scoping review of 21 studies, selected from PubMed and Embase searches, examined adults undergoing cardiac surgery with cardiopulmonary bypass.
- Predictors were grouped as patient-related, procedure-related, or postoperative, and as independent or non-independent.
- Intubation duration, transesophageal echocardiography use, reoperation, and multi-valve procedures were consistently associated with swallowing dysfunction.
- Instrumental assessments identified more granular independent predictors, while bedside screening identified factors tied to functional status and perioperative management.
- This single-case report describes one late-preterm neonate (35+3 weeks) with 2:1 pseudoatrioventricular block and a corrected QT of 495 ms, treated on day of life 4.
- The infant received an epicardial VVI pacemaker via lower partial sternotomy with a supradiaphragmatic pocket, under total intravenous anesthesia that avoided volatile and QT-prolonging agents.
- No intraoperative arrhythmia occurred, but postoperative genetic testing identified a KCNQ1 variant confirming LQT1, contrary to the preoperative assumption of a sodium channelopathy.
- The authors conclude that this pattern can occur in LQT1 and that a genotype-agnostic TIVA strategy was appropriate; the infant was discharged on day 15 without further events.
AI summary not available. Read the source abstract on PubMed.
- Single-center, single-blind randomized trial in a French cardiac surgery center enrolling 128 adults undergoing elective cardiac surgery with cardiopulmonary bypass, 126 analyzed.
- Patients received bilateral ultrasound-guided deep parasternal intercostal plane blocks with 40 mL ropivacaine versus standard care.
- The primary outcome, Quality of Recovery-15 at 24 hours, did not differ significantly (mean difference 3.9 points, 95% CI -3.3 to 11.2; p = 0.230), though resting pain was lower with the block at hours 2, 6, and 48.
- The authors conclude the block did not improve 24-hour recovery in mixed patients, and a non-prespecified subgroup analysis in internal mammary artery harvesting patients (n = 71) suggested possible benefit needing confirmation.
- Retrospective cohort of 530 adults on VA-ECMO with acquired von Willebrand syndrome across German hospitals, using 2019-2023 reimbursement data.
- Compared 389 patients who received any dose of von Willebrand factor (VWF) with patients who did not receive it.
- VWF-treated patients had less intracranial hemorrhage (8% vs 15%, p=0.0238) and shorter ICU stay (14 vs 18 days, p=0.0168), but more haemothorax (37% vs 20%, p=0.0028).
- Thromboembolic events did not differ between groups, and 90-day survival was numerically higher with VWF but not statistically significant (p=0.188).
- Retrospective single-center cohort of 149 adults receiving VA-ECMO for postcardiotomy cardiogenic shock, 2007-2024, with 7 bridged to transplant excluded.
- A four-variable score (age, pre-ECMO lactate, peripheral artery disease, preoperative RV dysfunction) was built at implantation and compared with EuroSCORE II, APACHE II, and lactate.
- ECMO-PoCS had AUC 0.715, higher than EuroSCORE II (0.583; p=0.043) and lactate alone (0.601; p=0.030), but not significantly higher than APACHE II (0.610; p=0.13).
- Adding the variables to APACHE II raised its AUC to 0.727, and the authors limit use to risk description and research pending external validation.
- Retrospective chart review of 56 infants undergoing arterial switch operation at one quaternary children's hospital, July 2018 to December 2025.
- 34 infants (61%) received rFVIIa, with a median first dose of 50 mcg/kg, and 22 did not; perioperative and postoperative outcomes were compared.
- Chest tube output, length of stay, and time to extubation were similar between groups, and thrombotic complications were 9% vs 14% (p = 0.670).
- The authors found that patients receiving rFVIIa had more post-bypass transfusion, and they note the observational design and few thrombotic events limit their conclusions.
- Retrospective multicenter cohort of 574 adults with LVEF ≤40% undergoing isolated CABG at four German academic centers from 2017 to 2023, of whom 70 (12.2%) were women.
- Exposure studied was female sex, with postoperative ventilation duration and ventilation over 24 hours as primary outcomes; no intervention was assigned.
- Female sex was associated with +30.2% longer ventilation (95% CI -3.6% to +75.8%; p = 0.086, not significant) and higher odds of ventilation over 24 hours (aOR 1.82, 95% CI 1.01-3.26; p = 0.045).
- In 69 matched pairs, women had longer ventilation (16.0 vs 11.0 hours; p = 0.021) and more ventilation over 24 hours (30.9% vs 13.2%; p = 0.029), though the authors describe the estimates as model-dependent and hypothesis-generating.
- Systematic review of PubMed and Scopus pooling 23 published studies covering 207 patients with HIT or suspected HIT undergoing cardiopulmonary bypass.
- Iloprost or epoprostenol was given to inhibit platelet function so heparin could be used during bypass, followed by protamine reversal.
- Both agents permitted heparinization and protamine reversal, and norepinephrine was used for prostacyclin-mediated hypotension in 14 of 17 studies (82.3%).
- Transfusion occurred in 58.9% of patients and thrombotic events in 8.2%, with only 1 of 207 (0.5%) thrombosing during bypass itself.
- This scoping review (PRISMA-ScR, searches of MEDLINE, Embase, and Scopus through July 2025) included 16 studies of parenteral vasopressors in adults undergoing major surgery, totaling 6,927 patients.
- Most included studies were small, single-center, observational designs, mainly in cardiothoracic surgery, and compared a range of vasopressor regimens, with no two studies comparing identical regimens.
- Initiation criteria varied widely, split between hypotension-based triggers and vasoplegic syndrome, which was inconsistently defined; eight studies reported significant differences in postoperative outcomes between strategies.
- The authors found no vasopressor strategy with consistent benefit across studies and concluded the evidence is fragmented, calling for standardized definitions and adequately powered multicenter trials.
- This narrative review synthesizes literature on perioperative management of G6PD deficiency in patients undergoing cardiac surgery, noting a global prevalence of about 450 million individuals.
- It covers avoiding oxidative stress and triggering medications, and notes that propofol, dexmedetomidine, and remifentanil may have antioxidant properties.
- Centrifugal pumps and minimized CPB circuitry are described as producing less inflammation than roller pumps or conventional circuits, and normothermia may help prevent hemolysis.
- The authors conclude that strategies to mitigate intraoperative hemolysis are needed and that clinicians should watch closely for signs of hemolysis.
- Retrospective observational cohort of 2,070 adults undergoing off-pump CABG at a single tertiary cardiac surgery center with continuous arterial pressure monitoring.
- The authors built a weight-time-frequency score combining depth, duration, and frequency of intraoperative MAP below 65 mmHg lasting at least 1 minute, with no intervention assigned.
- Each 10-point increase in the score was associated with higher adjusted odds of AF (OR 1.155, 95% CI 1.001-1.333), AKI (OR 1.216, 95% CI 1.001-1.478), and 30-day mortality (OR 2.346, 95% CI 1.332-4.130).
- The mortality estimate rests on only 31 deaths, and the score met noninferiority against MAP-based metrics in 14 of 15 comparisons, though gains for AF were minimal.
- Systematic review of three randomized controlled trials including 168 adults with type 2 diabetes undergoing cardiac surgery.
- Compared liraglutide added to insulin with insulin alone or placebo, assessing perioperative glucose, variability, insulin adjustments, and hypoglycemia.
- Liraglutide was associated with lower glucose, reduced glycemic variability, and fewer insulin adjustments, with low hypoglycemia, though the abstract reports no effect sizes or p values.
- Nausea and vomiting were more frequent with liraglutide; the authors call the evidence preliminary and call for larger, standardized trials with long-term outcomes.
AI summary not available. Read the source abstract on PubMed.
- Systematic review and meta-analysis of 14 reports of randomized trials (1,773 participants in the primary synthesis), all conducted in China, in adults undergoing cardiac surgery.
- Compared remimazolam-based with propofol-based general anesthesia for induction and maintenance.
- Remimazolam was associated with fewer trial-defined intraoperative hypotension (OR 0.31; 95% CI 0.20-0.47) and bradycardia events (OR 0.20; 95% CI 0.12-0.34), and shorter mechanical ventilation (MD -1.84 hours; 95% CI -2.34 to -1.35).
- Length of stay did not reach significance (MD -0.48 days; 95% CI -0.99 to 0.02; p = 0.06), major morbidity and mortality could not be pooled, and certainty was very low.
- Single-center, prospective cluster-randomized trial by month in cardiac surgery patients receiving intraoperative cryoprecipitate, stopped early at 170 of 502 planned patients.
- Pathogen-reduced cryoprecipitated fibrinogen complex (PR CRYO, storable at room temperature post-thaw) was compared with conventional cryoprecipitate (Cryo).
- Total blood components transfused were identical (6 units, IQR 3-12, p > 0.9), while PR CRYO was issued 19 min faster (12 vs. 31 min, p < 0.001) and transfusion began 16 min sooner (46 vs. 62 min, p = 0.008).
- No reduction in 30-day transfusions was shown, adverse events and 3-day transfusions were similar, and equivalence could not be formally concluded.
- Retrospective, single-center cohort of 38 consecutive adults who received prone positioning for acute respiratory failure within 30 days of median sternotomy, from 2004 to 2024.
- Protocolized prone sessions were given under deep sedation, neuromuscular blockade, and advanced hemodynamic monitoring, with a median duration of 24 hours.
- The PaO2/FiO2 ratio rose from 82.8 ± 26.1 mmHg at baseline to 175.0 ± 70.8 mmHg at completion (p < 0.001), with no significant hemodynamic deterioration.
- Mediastinitis or sternal dehiscence occurred in one patient (2.6%), and mortality was 44.7%; age ≥75 and baseline hypercapnia predicted death. The authors consider prone positioning reasonable for selected patients.
- This prospective randomized trial enrolled 271 adults undergoing elective sternotomy at a single center, randomized 1:1:1 to standard therapy, ESP block, or SPIP block.
- Both fascial plane blocks were added to a multimodal analgesic regimen and compared with the control group receiving standard therapy alone.
- Opioid use did not differ significantly on postoperative days 0 to 2; a day 3 difference favored ESP (p = 0.047). Maximum pain scores were lower in both block groups on days 0 to 3 (POD 1 p < 0.001, POD 2 p < 0.001, POD 3 p = 0.002).
- The authors conclude that patients undergoing sternotomy may benefit from adding either ESP or SPIP blocks to a multimodal postoperative regimen.